Secondary metabolites from plants inhibiting ABC transporters and reversing resistance of cancer cells and microbes to cytotoxic and antimicrobial agents

Frontiers in Microbiology

Volumn 3, Issue APR, 2012, Pages

  Wink, Michael ^a   Ashour, Mohamed L ^b   El Readi, Mahmoud Zaki ^a,c  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b Ain Shams University   (Egypt)

^c Al Azhar University   (Egypt)

Author keywords

ABC transporter; MDR; MRP1; P gp; Review; Secondary metabolites

Indexed keywords

EID: 84867623825     PISSN: None     EISSN: 1664302X     Source Type: Journal    
DOI: 10.3389/fmicb.2012.00130     Document Type: Review

References (199)

1. Adams, M., Mahringer, A., Kunert, O., Fricker, G., Efferth, T., and Bauer, R. (2007). Cytotoxicity and p-glycoprotein modulating effects of quinolones and indoloquinazolines from the Chinese herb Evodia rutaecarpa. PlantaMed. 73, 1554-1557.
2. Agarwal, R., Agarwal, C., Ichikawa, H., Singh, R. P., and Aggarwal, B. B. (2006). Anticancer potential of silymarin, from bench to bed side. Anticancer Res. 26, 4457-4498.
3. Ambudkar, S. V., Dey, S., Hrycyna, C. A., Ramachandra, M., Pastan, I., and Gottesman,M. M. (1999).Biochemical, cellular, and pharmacological aspects of the multidrug transporter. Annu. Rev. Pharmacol. Toxicol. 39, 361-398.
4. An, G., Wu, F., and Morris, M. E. (2011). 5,7-Dimethoxyflavone and multiple flavonoids in combination alter the ABCG2-mediated tissue distribution of mitoxantrone in mice. Pharm. Res. 28, 1090-1099.
5. Andrade, A. C., Del Sorbo, G., Van Nistelrooy, J. G., and Waard, M. A. (2000). The ABC transporter AtrB from Aspergillus nidulans mediates resistance to all major classes of fungicides and some natural toxic compounds. Microbiology 146, 1987-1997.
6. Angelini, A., Di Ilio, C., Castellani, M. L., Conti, P., and Cuccurullo, F. (2010). Modulation of multidrug resistance p-glycoprotein activity by flavonoids and honokiol in human doxorubicin-resistant sarcoma cells (MES-SA/DX-5), implications for natural sedatives as chemosensitizing agents in cancer therapy. J. Biol. Regul. Homeost. Agents 24, 197-205.
7. Annereau, J. P., Szakács, G., Tucker, C. J., Arciello, A., Cardarelli, C., Collins, J., Grissom, S., Zeeberg, B. R., Reinhold, W., Weinstein, J. N., Pommier, Y., Paules, R. S., and Gottesman, M. M. (2004). Analysis of ATP-binding cassette transporter expression in drug-selected cell lines by a microarray dedicated to multidrug resistance. Mol. Pharmacol. 66, 1397-1405.
8. Arora, A., and Shukla, Y. (2003). Modulation of vinca-alkaloid induced P-glycoprotein expression by indole-3-carbinol. Cancer Lett. 189,167-173.
9. Beck, W. T., Cirtain, M. C., Glover, C. J., Felsted, R. L., and Safa, A. R. (1988). Effects of indole alkaloids on multidrug resistance and labeling of P-glycoprotein by a photoaffinity analog of vinblastine. Biochem. Biophys. Res. Commun. 153, 959-966.
10. Belofsky, G., Percivill, D., Lewis, K., Tegos, G. P., and Ekart, J. (2004). Phenolic metabolites of Dalea versi-color that enhance antibiotic activity against model pathogenic bacteria. J. Nat. Prod. 67,481-484.
11. Berek, L., Szabo, D., Petri, I. B., Shoyama, Y., Lin, Y. H., and Molnar, J. (2001). Effects of naturally occurring glucosides, solasodine glucosides, ginsenosides and parishin derivatives on multidrug resistance of lymphoma cells and leukocyte functions. In vivo 15,151-156.
12. Bhardwaj, R. K., Glaeser, H., Becquemont, L., Klotz, U., Gupta, S. K., and Fromm, M. F. (2002). Piperine, a major constituent of black pepper, inhibits human P-glycoprotein and CYP3A4. J. Pharmacol. Exp. Ther. 302,645-650.
13. Bhat, U. G., Winter, M. A., Pearce, H. L., andBeck,W.T. (1995). A structure-function relationship among reserpine and yohimbine analogues in their ability to increase expression of mdr1 and P-glycoprotein in a human colon carcinoma cell line. Mol. Pharmacol. 48, 682-689.
14. Brooks, T. A., Minderman, H., O'Loughlin, K. L., Pera, P., Ojima, I., Baer, M. R., and Bernacki, R. J. (2003). Taxane-based reversal agents modulate drug resistance mediated by P-glycoprotein, multidrug resistance protein, and breast cancer resistance protein. Mol. Cancer Ther. 2,1195-1205.
15. Cavet, M. E., West, M., and Simmons, N. L. (1996). Transport and epithelial secretion of the cardiac glycoside, digoxin, by human intestinal epithelial (Caco-2) cells. Br. J. Pharmacol. 118, 1389-1396.
16. Chanmahasathien, W., Ampasavate, C., Greger,H.,and Limtrakul,P. (2011). Stemona alkaloids, from traditional Thai medicine, increase chemosensitivity via P-glycoprotein-mediated multidrug resistance. Phytomedicine 18, 199-204.
17. Chauffert, B., Pelletier, H., Corda, C., Solary, E., Bedenne, L., Caillot, D., and Martin, F. (1990). Potential usefulness of quinine to circumvent the anthracycline resistance in clinical practice. Br. J. Cancer 62, 395-397.
18. Chen, G., Ramachandran, C., and Krishan, A. (1993). Thaliblastine, a plant alkaloid, circumvents multidrug resistance by direct binding to P-glycoprotein. Cancer Res. 53, 2544-2547.
19. Chen, G., Teicher, B. A., and Frei, E. (1996). Differential interactions of Pgp inhibitor thaliblastine with adriamycin, etoposide, taxol and anthrapyrazole CI941 in sensitive and multidrug-resistant human MCF-7 breast cancer cells. Anti-cancer Res. 16,3499-3505.
20. Chen, G., and Waxman, D. J. (1995). Complete reversal by thaliblastine of 490-fold adriamycin resistance in multidrug-resistant (MDR) human breast cancer cells. Evidence that multiple biochemical changes in MDR cells need not correspond to multiple functional determinants for drug resistance. J. Pharmacol. Exp. Ther. 274, 1271-1277.
21. Chieli, E., Romiti, N., Rodeiro, I., and Garrido, G. (2010). In vitro modulation of ABCB1/P-glycoprotein expression by polyphenols from Mangifera indica. Chem. Biol. Interact. 186,287-294.
22. Choi, C. H., Kang, G., and Min, Y D. (2003). Reversal of P-glycoprotein-mediated multidrug resistance by protopanaxatriol ginsenosides from Korean red ginseng. Planta Med. 69, 235-240.
23. Choi, S. U., Park, S. H., Kim, K. H., Choi, E. J., Kim, S., Park, W K., Zhang, Y H., Kim, H. S., Jung, N. P., and Lee, C. O. (1998). The bis-benzylisoquinoline alkaloids, tetrandine and fangchinoline, enhance the cytotoxicity of multidrug resistance-related drugs via modulation of P-glycoprotein. Anticancer Drugs 9, 255-261.
24. Chung, S. Y., Sung, M. K., Kim, N. H., Jang, J. O., Go, E. J., and Lee, H. J. (2005). Inhibition of P-glycoprotein by natural products in human breast cancer cells. Arch. Pharm. Res. 28, 823-828.
25. Chusri, S., Villanueva, I., Voravuthikunchai, S. P., and Davies, J. (2009). Enhancing antibiotic activity, a strategy to control Acinetobacter infections. J. Antimicrob. Chemother. 64, 1203-1211.
26. Conseil, G., Baubichon-Cortay, H., Dayan, G., Jault, J. M., Barron, D., and Di Pietro, A. (1998). Flavonoids, a class of modulators with bifunctional interactions at vicinal ATP-and steroid-binding sites on mouse P-glycoprotein. Proc. Natl. Acad. Sci. U.S.A. 95, 9831-9836.
27. Cooray, H. C., Janvilisri, T., van Veen, H. W., Hladky, S. B., and Barrand, M. A. (2004). Interaction of the breast cancer resistance protein with plant polyphenols. Biochem. Biophys. Res. Commun. 317,269-275.
28. Critchfield, J. W., Welsh, C. J., Phang, J. M., and Yeh, G. C. (1994). Modulation of adriamycin accumulation and efflux by flavonoids in HCT-15 colon cells. Activation of P-glycoprotein as a putative mechanism. Biochem. Pharmacol. 48, 1437-1445.
29. Cui, X. R., Tsukada, M., Suzuki, N., Shimamura, T., Gao, L., Koyanagi, J., Komada, F., and Saito, S. (2008). Comparison of the cytotoxic activities of naturally occurring hydroxyanthraquinones and hydroxynaphthoquinones. Eur. J. Med. Chem. 43, 1206-1215.
30. Dantzig, A. H., Law, K. L., Cao, J., and Starling, J. J. (2001). Reversal of multidrug resistance by the P-glycoprotein modulator, LY335979, from the bench to the clinic. Curr. Med. Chem. 8, 39-50.
31. Dantzig, A. H., Shepard, R. L., Cao, J., Law, K. L., Ehlhardt, W J., Baughman, T. M., Bumol, T., and Starling, J. J. (1996). Reversal of P-glycoprotein-mediated multidrug resistance by a potent cyclopropyldibenzosuberane modulator, LY335979. Cancer Res. 56,4171-4179.
32. de Castro, W V., Mertens-Talcott, S., Derendorf, H., and Butterweck, V. (2007). Grapefruit juice-drug interactions, grapefruit juice and its components inhibit P-glycoprotein (ABCB1) mediated transport of talinolol in Caco-2 cells. J. Pharm. Sci. 96,2808-2817.
33. de Castro, W V., Mertens-Talcott, S., Derendorf, H., and Butterweck, V. (2008). Effect of grapefruit juice, naringin, naringenin, and bergamottin on the intestinal carrier-mediated transport of talinolol in rats. J. Agric. Food Chem. 56, 4840-4845.
34. de Lannoy, I. A., and Silverman, M. (1992). The MDR1 gene product, P-glycoprotein, mediates the transport of the cardiac glycoside, digoxin. Biochem. Biophys. Res. Commun. 189,551-557.
35. de Wet, H., McIntosh, D. B., Conseil, G., Baubichon-Cortay, H., Krell, T., Jault, J. M., Daskiewicz, J. B., Barron, D., and Di Pietro, A. (2001). Sequence requirements of the ATP-binding site within the C-terminal nucleotide-binding domain of mouse P-glycoprotein, structure-activity relationships for flavonoid binding. Biochemistry 40, 10382-10391.
36. Ding, Z., Tang, S. C., Weerasinghe, P., Yang, X., Pater, A., and Liepins, A. (2002). The alkaloid sanguinarine is effective against multidrug resistance in human cervical cells via bimodal cell death. Biochem. Pharmacol. 63, 1415-1421.
37. Distefano, M., Scambia, G., Ferlini, C., Gaggini, C., De Vincenzo, R., Riva, A., Bombardelli, E., Ojima, I., Fattorossi, A., Panici, P. B., and Mancuso, S. (1997). Anti-proliferative activity of a new class of taxanes (14beta-hydroxy-10-deacetylbaccatin III derivatives) on multidrug-resistance-positive human cancer cells. Int. J. Cancer 72,844-850.
38. Dorr, R. T., Liddil, J. D., Von Hoff, D. D., Soble, M., and Osborne, C. K. (1989). Antitumor activity and murine pharmacokinetics of parenteral acronycine. Cancer Res. 49, 340-344.
39. Duarte, N., Gyemant, N., Abreu, P. M., Molnar, J., and Ferreira, M. J. (2006). New macrocyclic lathyrane diterpenes, from Euphorbia lagascae, as inhibitors of multidrug resistance of tumour cells. Planta Med. 72, 162-168.
40. Duarte, N., Lage, H., Abrantes, M., and Ferreira, M. J. (2010). Phenolic compounds as selective anti-neoplasic agents against multidrug-resistant human cancer cells. Planta Med. 76, 975-980.
41. Duarte, N., Ramalhete, C., Varga, A., Molnar, J., and Ferreira, M. J. (2009). Multidrug resistance modulation and apoptosis induction of cancer cells by terpenic compounds isolated from Euphorbia species. Anticancer Res. 29, 4467-4472.
42. Efferth, T., Chen, Z., Kaina, B., and Ag, W. (2005). Molecular determinants of response of tumor cells to berberine. Cancer Genomics Proteomics 2, 115-123.
43. Efferth, T., Sauerbrey, A., Halatsch, M. E., Ross, D. D., and Gebhart, E. (2003). Molecular modes of action of cephalotaxine and homoharring-tonine from the coniferous tree Cephalotaxus hainanensis in human tumor cell lines. Naunyn Schmiede-bergs Arch. Pharmacol. 367, 56-67.
44. El-Readi, M. Z., Hamdan, D., Farrag, N., El-Shazly, A., and Wink, M. (2010). Inhibition of P-glycoprotein activity by limonin and other secondary metabolites from Citrus species in human colon and leukaemia cell lines. Eur. J. Pharmacol. 626, 139-145.
45. Elsinga, P. H., Hendrikse, N. H., Bart, J., Vaalburg, W., and van Waarde, A. (2004). PET studies on P-glycoprotein function in the blood-brain barrier, how it affects uptake and binding of drugs within the CNS. Curr. Pharm. Des. 10, 1493-1503.
46. Etheridge, A. S., Black, S. R., Patel, P. R., So, J., and Mathews, J. M. (2007). An in vitro evaluation of cytochrome P450 inhibition and P-glycoprotein interaction with goldenseal, Ginkgo biloba, grape seed, milk thistle, and ginseng extracts and their constituents. Planta Med. 73, 731-741.
47. Falcao-Silva, V. S., Silva, D. A., Souza Mde, F., and Siqueira-Junior, J. P. (2009). Modulation of drug resistance in Staphylococcus aureus by a kaempferol glycoside from Herissantia tiubae (Malvaceae). Phytother. Res. 23, 1367-1370.
48. Faria, N. C. G., Kim, J. H., Goncalves, L., Martins, M., Chan, K. L., and, Campbell, B. (2011). Enhanced activity of antifungal drugs using natural phenolics against yeast strains of Candida and Cryptococcus. Lett. Appl. Micobiol. 5,506-513.
49. Fernandes, J., Castilho, R. O., da Costa, M. R., Wagner-Souza, K., Coelho Kaplan, M. A., and Gattass, C. R. (2003). Pentacyclic triterpenes from Chrysobalanaceae species, cytotoxicity on multidrug resistant and sensitive leukemia cell lines. Cancer Lett. 190, 165-169.
50. Foster, B. C., Foster, M. S., Vandenhoek, S., Krantis, A., Budzinski, J. W., Arnason, J. T., Gallicano, K. D., and Choudri, S. (2001). An in vitro evaluation of human cytochrome P450 3A4 and P-glycoprotein inhibition by garlic. J. Pharm. Pharm. Sci. 4, 176-184.
51. Fu, L., Liang, Y., Deng, L., Ding, Y., Chen, L., Ye, Y., Yang, X., and Pan, Q. (2004). Characterization of tetrandrine, a potent inhibitor of P-glycoprotein-mediated multidrug resistance. Cancer Chemother. Pharmacol. 53, 349-356.
52. Fu, L. W., Zhang, Y. M., Liang, Y. J., Yang, X. P., and Pan, Q. C. (2002), The multidrug resistance of tumour cells was reversed by tetrandrine in vitro and in xenografts derived from human breast adenocarcinoma MCF-7/adr cells. Eur. J. Cancer 38, 418-426.
53. Genne, P., Dimanche-Boitrel, M. T., Mauvernay, R. Y., Gutierrez, G., Duchamp, O., Petit, J. M., Martin, E, and Chauffert, B. (1992). Cinchonine, a potent efflux inhibitor to circumvent anthracycline resistance in vivo. Cancer Res. 52, 2797-2801.
54. Genne, P., Duchamp, O., Solary, E., Pinard, D., Belon, J. P., Dimanche-Boitrel, M. T., and Chauffert, B. (1994). Comparative effects of quinine and cinchonine in reversing multidrug resistance on human leukemic cell line K562/ADM. Leukemia 8,160-164.
55. Gibbons, S., Leimkugel, J., Oluwatuyi, M., and Heinrich, M. (2003). Activity of Zanthoxylum clavaherculis extracts against multi-drug resistant methicillin-resistant Staphylococcus aureus (mdr-MRSA). Phytother. Res. 17,274-275.
56. Gibbons, S., and Udo, E. E. (2000). The effect of reserpine, a modulator of multidrug efflux pumps, on the in vitro activity of tetracycline against clinical isolates of methicillin resistant Staphylococcus aureus (MRSA) possessing the tet(K) determinant. Phytother. Res. 14, 139-140.
57. Gillet, J. P., Efferth, T., Steinbach, D., Hamels, J., de Longueville, F., Bertholet, V., and Remacle, J. (2004). Microarray-based detection of multidrug resistance in human tumor cells by expression profiling of ATP-binding cassette transporter genes. Cancer Res. 64, 8987-8993.
58. Gottesman, M. M. (2002). Mechanisms of cancer drug resistance. Annu. Rev. Med. 53, 615-627.
59. Guengerich, F. P. (2001). Uncommon P450-catalyzed reactions. Curr. Drug Metab. 2,93-115.
60. Guo, X. L., Leng, P., Yang, Y., Yu, L. G., and Lou, H. X. (2008). Plagiochin E, a botanic-derived phenolic compound, reverses fungal resistance to fluconazole relating to the efflux pump. J. Appl. Microbiol. 104, 831-838.
61. Guz, N. R., Stermitz, F. R., Johnson, J. B., Beeson, T. D., Willen, S., Hsiang, J., and Lewis, K. (2001). Flavonolignan and flavone inhibitors of a Staphylococcus aureus multidrug resistance pump, structure-activity relationships. J. Med. Chem. 44, 261-268.
62. Gyemant, N., Tanaka, M., Antus, S., Hohmann, J., Csuka, O., Man-doky, L., and Molnar, J. (2005). In vitro search for synergy between flavonoids and epirubicin on multidrug-resistant cancer cells. In vivo 19,367-374.
63. Gyemant, N., Tanaka, M., Molnar, P., Deli, J., Mandoky, L., and Molnar, J. (2006), Reversal of multidrug resistance of cancer cells in vitro, modification of drug resistance by selected carotenoids. Anticancer Res. 26, 367-374.
64. Han, Y., Chin Tan, T. M., and Lim, L. Y (2008). In vitro and in vivo evaluation of the effects of piperine on P-gp function and expression. Toxicol. Appl. Pharmacol. 230, 283-289.
65. He, L., and Liu, G. Q. (2002). Effects of various principles from Chinese herbal medicine on rhodamine123 accumulation in brain capillary endothelial cells. Acta Pharmacol. Sin. 23,591-596.
66. Hebestreit, P., and Melzig, M. (2003). Cytotoxic activity of the seeds from Agrostemma githago var. githago. Planta Med. 69,921-925.
67. Hohmann, J., Molnar, J., Redei, D., Evanics, F., Forgo, P., Kalman, A., Argay, G., and Szabo, P. (2002). Discovery and biological evaluation of a new family of potent modulators of multidrug resistance, reversal of multidrug resistance of mouse lymphoma cells by new natural jatrophane diterpenoids isolated from Euphorbia species. J. Med. Chem. 45, 2425-2431.
68. Hou, X. L., Takahashi, K., Tanaka, K., Tougou, K., Qiu, F., Komatsu, K., and Azuma, J. (2008). Curcuma drugs and curcumin regulate the expression and function of P-gp in Caco-2 cells in completely opposite ways. Int. J. Pharm. 358, 224-229.
69. Hu, X. F., Slater, A., Wall, D. M., Kantharidis, P., Parkin, J. D., Cowman, A., and Zalcberg, J. R. (1995). Rapid up-regulation of mdr1 expression by anthracyclines in a classical multidrug-resistant cell line. Br. J. Cancer 71, 931-936.
70. Hyafil, F., Vergely, C., Du Vignaud, P., and Grand-Perret, T. (1993). In vitro and in vivo reversal of multidrug resistance by GF120918, an acridonecarboxamide derivative. Cancer Res. 53,4595-4602.
71. Ignacimuthu, S., and Shanmugam, N. (2010). Antimycobacterial activity of two natural alkaloids, vasicine acetate and 2-acetyl benzylamine, isolated from Indian shrub Adhatoda vasica Nees. leaves. J. Biosci. 35, 565-570.
72. Ikeda, R., Che, X. F., Yamaguchi, T., Ushiyama, M., Zheng, C. L., Okumura, H., Takeda, Y., Shibayama, Y., Nakamura, K., and Jeung, H. C. (2005). Cepharanthine potently enhances the sensitivity of anti-cancer agents in K562 cells. Cancer Sci. 96, 372-376.
73. Ingelman-Sundberg, M., and Gomez, A. (2010). The past, present and future of pharmacoepigenomics. Pharmacogenomics 11, 625-662.
74. Ivanova, A., Serly, J., Christov, V., Stamboliyska, B., and Molnar, J. (2011). Alkaloids derived from genus Veratrum and Peganum of Mongolian origin as multidrug resistance inhibitors of cancer cells. Fitoterapia 82, 570-575.
75. Ivanova, A., Serly, J., Dinchev, D., Ocsovszki, I., Kostova, I., and Molnar, J. (2009). Screening of some saponins and phenolic components of Tribulus terrestris and Smilax excelsa as MDR modulators. In vivo 23,545-550.
76. Jeong, Y H., Chung, S. Y., Han, A. R., Sung, M. K., Jang, D. S., Lee, J., Kwon, Y., Lee, H. J., and Seo, E. K. (2007). P-glycoprotein inhibitory activity of two phenolic compounds, (-)-syringaresinol and tricin from Sasa borealis. Chem. Biodivers. 4, 12-16.
77. Kam, T. S., Sim, K. M., Pang, H. S., Koyano, T., Hayashi, M., and Komiyama, K. (2004). Cytotoxic effects and reversal of multidrug resistance by ibogan and related indole alkaloids. Bioorg. Med. Chem. Lett. 14, 4487-4489.
78. Kam, T. S., Subramaniam, G., Sim, K. M., Yoganathan, K., Koyano, T., Toyoshima, M., Rho, M. C., Hayashi, M., and Komiyama, K. (1998). Reversal of multidrug resistance (MDR) by aspidofractinine-type indole alkaloids. Bioorg. Med. Chem. Lett. 8, 2769-2772.
79. Kars, M. D., Iseri, O. D., Gunduz, U., and Molnar, J. (2008). Reversal of multidrug resistance by synthetic and natural compounds in drug-resistant MCF-7 cell lines. Chemotherapy 54,194-200.
80. Kashiwada, Y., Nishimura, K., Kurimoto, S., and Takaishi, Y. (2011). New29-nor-cycloartanes with a 3,4-seco-and a novel 2,3-seco-structure from the leaves of Sinocalycanthus chinensis. Bioorg. Med. Chem. 19, 2790-2796.
81. Katsui, K., Kuroda, M., Wang, Y., Komatsu, M., Himei, K., Takemoto, M., Akaki, S., Asaumi, J., Kanazawa, S., and Hiraki, Y (2004). Cepharanthine enhances adriamycin sensitivity by synergistically accelerating apoptosis for adriamycin-resistant osteosarcoma cell lines, SaOS2-AR and SaOS2 F-AR. Int. J. Oncol. 25, 47-56.
82. Kim, J. H., Campbell, B. C., Mahoney, N., Chan, K. L., and Molyneux, R. J. (2010). Chemosensitization of afla-toxigenic fungi to antimycin A and strobilurin using salicylaldehyde, a volatile natural compound targeting cellular antioxidation system. Mycopathologia 171,291-298.
83. Kim, J. H., Campbell, B. C., Mahoney, N., Chan, K. L., Molyneux, R. J., and May, G. (2007). Enhanced activity of strobilurin and fludioxonil by using berberine and phenolic compounds to target fungal antioxidative stress response. Lett. Appl. Microbiol. 45, 134-141.
84. Kitagawa, S., Nabekura, T., Nakamura, Y., Takahashi, T., and Kashiwada, Y. (2007). Inhibition of P-glycoprotein function by tannic acid and penta-galloylglucose. J. Pharm. Pharmacol. 59,965-969.
85. Kolaczkowski, M., Kolaczowska, A., Luczynski, J., Witek, S., and Goffeau, A. (1998). In vivo characterization of the drug resistance profile of the major ABC transporters and other components of the yeast pleiotropic drug resistance network. Microb. DrugResist. 4, 143-158.
86. Krishnamurthy, P., and Schuetz, J. D. (2006). Role of ABCG2/BCRP in biology and medicine. Annu. Rev. Pharmacol Toxicol. 46,381-410.
87. Kuete, V., Ngameni, B., Tangmouo, J. G., Bolla, J. M., Alibert-Franco, S., Ngadjui, B. T., and Pages, J. M. (2010). Efflux pumps are involved in the defense of Gramnegative bacteria against the natural products isobavachalcone and diospyrone. Antimicrob. Agents Chemother. 54,1749-1752.
88. Kurimoto, S., Kashiwada, Y., Lee, K. H., and Takaishi, Y (2011a). Triterpenes and a triterpene glucoside from Dysoxylum cumingianum. Phytochemistry 72, 2205-2211.
89. Kurimoto, S., Kashiwada, Y., Morris-Natschke, S. L., Lee, K. H., and Takaishi, Y (2011b). Dyscusins A-C, three new steroids from the leaves of Dysoxylum cumingianum. Chem. Pharm. Bull. 59, 1303-1306.
90. Lavie, Y., Harel-Orbital, T., Gaffield, W., and Liscovitch, M. (2001). Inhibitory effect of steroidal alkaloids on drug transport and multidrug resistance in human cancer cells. Anticancer Res. 21, 1189-1194.
91. Lee, S. W., Hwang, B. Y., Kim, S. E., Kim, H. M., Kim, Y H., Lee, K. S., Lee, J. J., and Ro, J.-S. (1995). Isolation of modulators for multidrug resistance from the fruits of Evodia officinalis. Korean J. Physiol. Pharmacol. 26, 344-348.
92. Lee, S. Y., Rhee, Y H., Jeong, S. J., Lee, H. J., Jung, M. H., Kim, S. H., Lee, E. O., and Ahn, K. S. (2011). Hydrocin-chonine, cinchonine, and qiuinidine potentiate paclitaxel-induced cyto-toxicity and apoptosis via multidrug resistance reversal in MES-SA/DX5 uterine sarcoma cells. Environ. Toxicol. 26,424-431.
93. Lee,Y.-J.,Yamamoto,K., Hamamoto,H., Nakaune, R., and Hibi, T. (2005). A novel ABC transporter gene ABC2 involved in multidrug susceptibility but not pathogenicity in rice blast fungus, Magnaporthe grisea. Pestic. Biochem. Physiol. 81, 13-23.
94. Lee, Y S., Kang, O. H., Choi, J. G., Oh, Y C, Keum, J. H., Kim, S. B., Jeong, G. S., Kim, Y C, Shin, D. W., and Kwon, D. Y. (2010). Synergistic effect of emodin in combination with ampicillin or oxacillin against methicillin-resistant Staphylococcus aureus. Pharm. Biol. 48, 1285-1290.
95. Leslie, E. M., Mao, Q., Oleschuk, C. J., Deeley, R. G., and Cole, S. P. (2001). Modulation of multidrug resistance protein 1 (MRP1/ABCC1) transport and ATPase activities by interaction with dietary flavonoids. Mol. Pharmacol. 59,1171-1180.
96. Li, M.C.,Yao,Z., Takaishi, Y., Tang, S. A., and Duan, H. Q. (2011a). Isolation of novel phenolic compounds with multidrug resistance (MDR) reversal properties from Onychiumjaponicum. Chem. Biodivers. 8,1112-1120.
97. Li,S.,Lei,Y.,Jia,Y.,Li,N.,Wink,M., and Ma, Y (2011b). Piperine, a piperidine alkaloid from Piper nigrum resensitizes P-gp, MRP1 and BCRP dependent multidrug resistant cancer cells. Phytomedicine 19, 83-87.
98. Limtrakul, P., Chearwae, W., Shukla, S., Phisalphong, C., and Ambudkar, S. V. (2007). Modulation of function of three ABC drug transporters, P-glycoprotein (ABCB1), mitox-antrone resistance protein (ABCG2) and multidrug resistance protein 1 (ABCC1) by tetrahydrocurcumin, a major metabolite of curcumin. Mol. Cell. Biochem. 296, 85-95.
99. Liu, D. F., Li, Y P., Ou, T. M., Huang, S. L., Gu, L. Q., Huang, M., and Huang, Z. S. (2009). Synthesis and antimultidrug resistance evaluation of icariin and its derivatives. Bioorg. Med. Chem. Lett. 19,4237-4240.
100. Loo, T. W., and Clarke, D. M. (2005). Recent progress in understanding the mechanism of P-glycoprotein-mediated drug efflux. J. Membr. Biol. 206, 173-185.
101. Lu, J. J., Cai, Y J., and Ding, J. (2012). The short-time treatment with curcumin sufficiently decreases cell viability, induces apoptosis and copper enhances these effects in multidrug-resistant K562/A02 cells. Mol. Cell. Biochem. 360, 253-260.
102. Ma, Y., and Wink, M. (2008). Lobeline, a piperidine alkaloid from Lobelia can reverse P-gp dependent multidrug resistance in tumor cells. Phytomedicine 15, 754-758.
103. Ma, Y., and Wink, M. (2009). 'Reversal of multidrug resistance (MDR) by the isoquinoline alkaloid glaucine,' in Multiple Drug Resistance, eds A. Meszaros and G. Balogh (Hauppauge: Nova Science Publishers), 1-19.
104. Ma, Y., and Wink, M. (2010). The betacarboline alkaloid harmine inhibits BCRP and can reverse resistance to the anticancer drugs mitoxantrone and camptothecin. Phytother. Res. 24, 146-149.
105. Madureira, A. M., Spengler, G., Molnar, A., Varga, A., Molnar, J., Abreu, P. M., and Ferreira, M. J. (2004). Effect of cycloartanes on reversal of multidrug resistance and apoptosis induction on mouse lymphoma cells. Anticancer Res. 24, 859-864.
106. Mahringer, A., and Fricker, G. (2010). BCRP at the blood-brain barrier, genomic regulation by 17β-estradiol. Mol. Pharm. 7,1835-1847.
107. Maliepaard, M., van Gastelen, M. A., Tohgo, A., Hausheer, F. H., van Waardenburg, R. C., de Jong, L. A., Pluim, D., Beijnen, J. H., and Schellens, J. H. (2001). Circumvention of breast cancer resistance protein (BCRP)-mediated resistance to camptothecins in vitro using non-substrate drugs or the BCRP inhibitor GF120918. Clin. Cancer Res. 7, 935-941.
108. Mao, Q., and Unadkat, J. D. (2005). Role of the breast cancer resistance protein (ABCG2) in drug transport. AAPSJ. 7, E118-E133.
109. Markham, P. N., Westhaus, E., Klyachko, K., Johnson, M. E., and Neyfakh, A. A. (1999). Multiple novel inhibitors of the NorA multidrug transporter of Staphylococcus aureus. Antimicrob. Agents Chemother. 43, 2404-2408.
110. Martins, A., Vasas, A., Schelz, Z., Viveiros, M., Molnar, J., Hohmann, J., and Amaral, L. (2010). Constituents of Carpobrotus edulis inhibit P-glycoprotein of MDR1-transfected mouse lymphoma cells. Anticancer Res. 30,829-835.
111. Mattern, M. R., Hofmann, G. A., Polsky, R. M., Funk, L. R., McCabe, F. L., and Johnson, R. K. (1993). In vitro and in vivo effects of clinically important camptothecin analogues on multidrug-resistant cells. Oncol. Res. 5, 467-474.
112. Mei, Y., Qian, F., Wei, D., and Liu, J. (2004). Reversal of cancer multidrug resistance by green tea polyphenols. J. Pharm. Pharmacol. 56,1307-1314.
113. Meschini, S., Marra, M., Calcabrini, A., Federici, E., Galeffi, C., and Arancia, G. (2003). Voacamine, a bisindolic alkaloid from Peschiera fuchsiaefolia, enhances the cytotoxic effect of doxorubicin on multidrug-resistant tumor cells. Int. J. Oncol. 23, 1505-1513.
114. Meschini, S., Marra, M., Condello, M., Calcabrini, A., Federici, E., Dupuis, M. L., Cianfriglia, M., and Arancia, G. (2005). Voacamine, an alkaloid extracted from Peschiera fuchsiaefolia, inhibits P-glycoprotein action in multidrug-resistant tumor cells. Int. J. Oncol. 27, 1597-1603.
115. Michalet, S., Cartier, G., David, B., Mariotte, A. M., Dijoux-Franca, M. G., Kaatz, G. W., Stavri, M., and Gibbons, S. (2007). N-caffeoylphenalkylamide derivatives as bacterial efflux pump inhibitors. Bioorg. Med. Chem. Lett. 17, 1755-1758.
116. Min, Y D., Choi, S. U., and Lee, K. R. (2006a). Aporphine alkaloids and their reversal activity of multidrug resistance (MDR) from the stems and rhizomes of Sinomenium acutum. Arch. Pharm. Res. 29, 627-632.
117. Min, Y D., Yang, M. C., Lee, K. H., Kim, K. R., Choi, S. U., and Lee, K. R. (2006b). Protoberberine alkaloids and their reversal activity of P-gp expressed multidrug resistance (MDR) from the rhizome of Coptis japonica Makino. Arch. Pharm. Res. 29,757-761.
118. Min, Y D., Kwon, H. C., Yang, M. C., Lee, K. H., Choi, S. U., and Lee, K. R. (2007). Isolation of limonoids and alkaloids from Phellodendron amurense and their multidrug resistance (MDR) reversal activity. Arch. Pharm. Res. 30, 58-63.
119. Möller, M., Weiss, J., and Wink, M. (2006). Reduction of cytotoxicity of the alkaloid emetine through P-glycoprotein (MDR1/ABCB1) in human Caco-2 cells and leukaemia cell lines. Planta Med. 72, 1121-1126.
120. Molnár, J., Engi, H., Gyémánt, N., Schelz, Z., Spengler, G., Ocsovski, I., Szücs, M., Hohmann, J., Szabo, M., and Tanács, L. (2008). 'Multidrug resistance reversal in cancer cells by selected carotenoids, flavonoids and anthocyanins,' in Bioactive Hetero-cycles VI, Vol. 15, ed. N. Motohashi (Berlin: Springer), 133-159. [Topics in Heterocyclic Chemistry].
121. Molnar, J., Gyemant, N., Mucsi, I., Molnar, A., Szabo, M., Kortvelyesi, T., Varga, A., Molnar, P., Toth, G. (2004). Modulation of multidrug resistance and apoptosis of cancer cells by selected carotenoids. In vivo 18,237-244.
122. Najar, I. A., Sachin, B. S., Sharma, S. C., Satti, N. K., Suri, K. A., and Johri, R. K. (2010). Modulation of P-glycoprotein ATPase activity by some phytoconstituents. Phytother. Res. 24, 454-458.
123. Nakajima, A., Yamamoto, Y., Taura, K., Hata, K., Fukumoto, M., Uchinami, H., Yonezawa, K., and Yamaoka, Y. (2004). Beneficial effect of cepha-ranthine on overcoming drug-resistance of hepatocellular carcinoma. Int. J. Oncol. 24, 635-645.
124. Nakaune, R. N., Hamamoto, H. H., Imada, J. I., Akutsu, K. A., and Hibi, T. H. (2002). A novel ABC transporter gene, is involved in multidrug resistance in the phytopathogenic fungus Penicillium digitatum. Mol. Genet. Genomics 267, 179-185.
125. Namanja, H. A., Emmert, D., Pires, M. M., Hrycyna, C. A., and Chmielewski, J. (2009). Inhibition of human P-glycoprotein transport and substrate binding using a galan-tamine dimer. Biochem. Biophys. Res. Commun. 388, 672-676.
126. Nielsen, D., and Skovsgaard, T. (1992). P-Glycoprotein as multidrug transporter-a critical-review of current multidrug resistant celllines. Biochim. Biophys. Acta 1139, 169-183.
127. Nissler, L., Gebhardt, R., and Berger, S. (2004). Flavonoid binding to a multi-drug-resistance transporter protein, an STD-NMR study. Anal. Bioanal. Chem. 379, 1045-1049.
128. Nooter, K., and Stoter, G. (1996). Molecular mechanisms of multidrug resistance in cancer chemotherapy. Pathol. Res. Pract. 192, 768-780.
129. O'Donnell, G., and Gibbons, S. (2007). Antibacterial activity of two canthin-6-one alkaloids from Allium neapolitanum. Phytother. Res. 21,653-657.
130. Ofer, M., Langguth, P., and Spahn-Langguth, H. (2006). Bidirectional membrane transport, simulations of transport inhibition in uptake studies explain data obtained with flavonoids. Eur. J. Pharm. Sci. 29, 251-258.
131. Ofer, M., Wolffram, S., Koggel, A., Spahn-Langguth, H., and Langguth, P. (2005). Modulation of drug transport by selected flavonoids: involvement of P-gp and OCT? Eur. J. Pharm. Sci. 25,263-271.
132. Ohtani, H., Ikegawa, T., Honda, Y., Kohyama, N., Morimoto, S., Shoyama, Y., Juichi, M., Naito, M., Tsuruo, T., and Sawada, Y (2007). Effects of various methoxyflavones on vincristine uptake and multidrug resistance to vincristine in P-gp-overexpressing K562/ADM cells. Pharm. Res. 24, 1936-1943.
133. Okura, T., Ibe, M., Umegaki, K., Shinozuka, K., and Yamada, S. (2010). Effects of dietary ingredients on function and expression of P-glycoprotein in human intestinal epithelial cells. Biol. Pharm. Bull. 33, 255-259.
134. Ordway, D., Hohmann, J., Viveiros, M., Viveiros, A., Molnar, J., Leandro, C., Arroz, M. J., Gracio, M. A., and Amaral, L. (2003). Carpobrotus edulis methanol extract inhibits the MDR efflux pumps, enhances killing of phagocytosed S. aureus and promotes immune modulation. Phytother. Res. 17,512-519.
135. Perez-Victoria, J. M., Chiquero, M. J., Conseil, G., Dayan, G., Di Pietro, A., Barron, D., Castanys, S., and Gamarro, F. (1999). Correlation between the affinity of flavonoids binding to the cytosolic site of Leish-mania tropica multidrug transporter and their efficiency to revert parasite resistance to daunomycin. Biochemistry 38, 1736-1743.
136. Rethy, B., Hohmann, J., Minorics, R., Varga, A., Ocsovszki, I., Molnar, J., Juhasz, K., Falkay, G., and Zupko, I. (2008). Antitumour properties of acridone alkaloids on a murine lymphoma cell line. Anticancer Res. 28, 2737-2743.
137. Robert, J., and Jarry, C. (2003). Multidrug resistance reversal agents. J. Med. Chem. 46,4805-4817.
138. Rocha Gda, G., Simoes, M., Lucio, K. A., Oliveira, R. R., Coelho Kaplan, M. A., and Gattass, C. R. (2007). Natural triterpenoids from Cecropia lyratiloba are cytotoxic to both sensitive and multidrug resistant leukemia cell lines. Bioorg. Med. Chem. 15, 7355-7360.
139. Rojas, R., Caviedes, L., Aponte, J. C., Vaisberg, A. J., Lewis, W. H., Lamas, G., Sarasara, C., Gilman, R. H., and Hammond, G. B. (2006). Aegicerin, the first oleanane triterpene with wide-ranging antimycobacterial activity, isolated from Clavija procera. J. Nat. Prod. 69, 845-846.
140. Scambia, G., Ranelletti, F. O., Panici, P. B., De Vincenzo, R., Bonanno, G., Ferrandina, G., Piantelli, M., Bussa, S., Rumi, C., and Cianfriglia, M. (1994). Quercetin potentiates the effect of adriamycin in a multidrug-resistant MCF-7 human breast-cancer cell line, P-glycoprotein as a possible target. Cancer Chemother. Pharmacol. 34,459-464.
141. Schinkel, A. H., and Jonker, J. W. (2003). Mammalian drug efflux transporters of the ATP binding cassette (ABC) family, an overview. Adv. DrugDeliv. Rev. 55, 3-29.
142. Severina, I. I., Muntyan, M. S., Lewis, K., and Skulachev, V P. (2001). Transfer of cationic antibacterial agents berberine, palmatine, and benzalkonium through bimolecular planar phospholipid film and Staphylococcus aureus membrane. IUBMB Life 52,321-324.
143. Shapiro, A. B., and Ling, V. (1997). Effect of quercetin on Hoechst 33342 transport by purified and reconstituted P-glycoprotein. Biochem. Pharmacol. 53, 587-596.
144. Sharma, S., Kumar, M., Nargotra, A., Koul, S., and Khan, I. A. (2010). Piperine as an inhibitor of Rv1258c, a putative multidrug efflux pump of Mycobacterium tuberculosis. J. Antimicrob. Chemother. 65, 1694-1701.
145. Smith, E. C., Kaatz, G. W., Seo, S. M., Wareham, N., Williamson, E. M., and Gibbons, S. (2007). The phenolic diterpene totarol inhibits multidrug efflux pump activity in Staphylococcus aureus. Antimicrob. Agents Chemother. 51, 4480-4483.
146. Solary, E., Mannone, L., Moreau, D., Caillot, D., Casasnovas, R. O., Guy, H., Grandjean, M., Wolf, J. E., Andre, F., and Fenaux, P. (2000). Phase I study of cinchonine, a multidrug resistance reversing agent, combined with the CHVP regimen in relapsed and refractory lympho-proliferative syndromes. Leukemia 14, 2085-2094.
147. Steffens, J. J., Pell, E. J., and Tien, M. (1996). Mechanisms of fungicide resistance in phytopathogenic fungi. Curr. Opin. Biotechnol. 7, 348-355.
148. Steinbach, D., Sell, W., Voigt, A., Hermann, J., Zintl, F., and Sauerbrey, A. (2002). BCRP gene expression is associated with a poor response to remission induction therapy in childhood acute myeloid leukemia. Leukemia 16, 1443-1447.
149. Stermitz, F. R., Beeson, T. D., Mueller, P. J., Hsiang, J., and Lewis, K. (2001). Staphylococcus aureus MDR efflux pump inhibitors from a Berberis and a Mahonia (sensu strictu) species. Biochem. Syst. Ecol. 29, 793-798.
150. Stermitz, F. R., Lorenz, P., Tawara, J. N., Zenewicz, L. A., and Lewis, K. (2000a). Synergy in a medicinal plant, antimicrobial action of berberine potentiated by 5'-methoxyhydnocarpin, a multidrug pump inhibitor. Proc. Natl. Acad. Sci. U.S.A. 97, 1433-1437.
151. Stermitz, F. R., Tawara-Matsuda, J., Lorenz, P., Mueller, P., Zenewicz, L., and Lewis, K. (2000b), 5'-Methoxyhydnocarpin-D and pheophorbide A, Berberis species components that potentiate berberine growth inhibition of resistant Staphylococcus aureus. J. Nat. Prod. 63, 1146-1149.
152. Stermitz, F. R., Scriven, L. N., Tegos, G., and Lewis, K. (2002). Two flavonols from Artemisia annua which potentiate the activity of berberine and norfloxacin against a resistant strain of Staphylococcus aureus. Planta Med. 68,1140-1141.
153. Suttana, W., Mankhetkorn, S., Poompimon, W., Palagani, A., Zhokhov, S., Gerlo, S., Haegeman, G., and Berghe, W. V (2010). Differential chemosensitization of P-glycoprotein overex-pressing K562/Adr cells by with-aferin A and Siamois polyphenols. Mol. Cancer 9, 99.
154. Suzuki, H., Tanabe, H., Mizukami, H., and Inoue, M. (2010). Selective regulation of multidrug resistance protein in vascular smooth muscle cells by the isoquinoline alkaloid coptisine. Biol. Pharm. Bull. 33, 677-682.
155. Tang, S., Bremner, P., Kortenkamp, A., Schlage, C., Gray, A. I., Gibbons, S., and Heinrich, M. (2003). Biflavonoids with cytotoxic and antibacterial activity from Ochna macrocalyx. Planta Med. 69, 247-253.
156. Taur, J. S., and Rodriguez-Proteau, R. (2008). Effects of dietary flavonoids on the transport of cimetidine via P-glycoprotein and cationic transporters in Caco-2 and LLC-PK1 cell models. Xenobiotica 38,1536-1550.
157. Tian,H.,andPan,O.C. (1997).Modulation of multidrug resistance by three bisbenzylisoquinolines in comparison with verapamil. Zhongguo Yao Li XueBao 18,455-458.
158. Tournier, N., Chevillard, L., Megarbane, B., Pirnay, S., Scherrmann, J. M., and Decleves, X. (2010). Interaction of drugs of abuse and maintenance treatments with human P-glycoprotein (ABCB1) and breast cancer resistance protein (ABCG2). Int. J. Neuropsychopharmacol. 13, 905-915.
159. Trompier, D., Baubichon-Cortay, H., Chang, X. B., Maitrejean, M., Barron, D., Riordon, J. R., and Di Pietro, A. (2003). Multiple flavonoid-binding sites within multidrug resistance proteinMRP1. Cell. Mol. LifeSci. 60, 2164-2177.
160. Twentyman, P. R., and Bleehen, N. M. (1991). Resistance modification by PSC-833, a novel non-immunosuppressive cyclosporin. Eur. J. Cancer 27, 1639-1642.
161. van der Kolk, D. M., Vellenga, E., Müller, M., and De Vries, E. G. E. (1999). Multidrug resistance protein MRP1, glutathione, and related enzymes-their importance in acute myeloid leukemia. Adv. Exp. Med. Biol. 457, 187-198.
162. van Gorkom, B. A., Timmer-Bosscha, H., de Jong, S., van der Kolk, D. M., Kleibeuker, J. H., and de Vries, E. G. (2002). Cytotoxicity of rhein, the active metabolite of sennoside laxatives, is reduced by multidrug resistance-associated protein 1. Br. J. Cancer 86, 1494-1500.
163. Versantvoort, C. H., Broxterman, H. J., Lankelma, J., Feller, N., and Pinedo, H. M. (1994). Competitive inhibition by genistein and ATP dependence of daunorubicin transport in intact MRP overexpressing human small cell lung cancer cells. Biochem. Pharmacol. 48, 1129-1136.
164. Versantvoort, C. H., Rhodes, T., and Twentyman, P. R. (1996). Acceleration of MRP-associated efflux of rhodamine 123 by genistein and related compounds. Br. J. Cancer 74, 1949-1954.
165. Wang, F. P., Wang, L., Yang, J. S., Nomura, M., and Miyamoto, K. (2005). Reversal of P-glycoprotein-dependent resistance to vinblastine by newly synthesized bisbenzylisoquinoline alkaloids in mouse leukemia P388 cells. Biol. Pharm. Bull. 28, 1979-1982.
166. Wang, L., Bai, L., Nagasawa, T., Hasegawa, T., Yang, X., Sakai, J., Bai, Y., Kataoka, T., Oka, S., and Hirose, K. (2008). Bioactive triterpene saponins from the ro ots of Phytolacca americana. J. Nat. Prod. 71, 35-40.
167. Watanabe, T., Tsuge, H., Oh-Hara, T., Naito, M., and Tsuruo, T. (1995). Comparative study on reversal efficacy of SDZ PSC 833, cyclosporin A and verapamil on multidrug resistance in vitro and in vivo. Acta Oncol 34,235-241.
168. Weerasinghe, P., Hallock, S., Tang, S. C., Trump, B., and Liepins, A. (2006). Sanguinarine overcomes P-glycoprotein-mediated multidrug-resistance via induction of apoptosis and oncosis in CEM-VLB 1000 cells. Exp. Toxicol. Pathol. 58, 21-30.
169. Wei, D., Mei, Y., and Liu, J. (2003). Quantification of doxorubicin and validation of reversal effect of tea polyphenols on multidrug resistance in human carcinoma cells. Biotechnol. Lett. 25,291-294.
170. Wesolowska, O., Hendrich, A. B., Laniapietrzak, B., Wisniewski, J., Molnar, J., Ocsovszki, I., and Michalak, K. (2009). Perturbation of the lipid phase of a membrane is not involved in the modulation of MRP 1 transport activity by flavonoids. Cell. Mol. Biol. Lett. 14, 199-221.
171. Wesolowska, O., Wisniewski, J., Duarte, N., Ferreira, M. J., and Michalak, K. (2007). Inhibition of MRP1 transport activity by phenolic and terpenic compounds isolated from Euphorbia species. Anticancer Res. 27,4127-4133.
172. Wijnholds, J., deLange, E. C., Scheffer, G. L., van den Berg, D. J., Mol, C. A., van der Valk, M., Schinkel, A. H., Scheper, R. J., Breimer, D. D., and Borst, P. (2000). Multidrug resistance protein 1 protects the choroid plexus epithelium and contributes to the blood-cerebrospinal fluid barrier. J. Clin. Invest. 105,279-285.
173. Wink, M. (1988). Plant breeding: importance of plant secondary metabolites for protection against pathogens and herbivores. Theor. Appl. Genet. 75, 225-233.
174. Wink, M. (1993). Allelochemical properties and the raison d'être of alkaloids. Alkaloids Chem. Biol. 43, 1-118.
175. Wink, M. (2000). Interference of alkaloids with neuroreceptors and ion channels. Nat. Prod. Res. 21, 3-129.
176. Wink, M. (2003). Evolution of secondary metabolites from an ecological and molecular phylogenetic perspective. Phytochemistry 64, 3-19.
177. Wink, M. (2007). Molecular modes of action of cytotoxic alkaloids-from DNA intercalation, spindle poisoning, topoisomerase inhibition to apoptosis and multiple drug resistance. Alkaloids Chem. Biol. 64,1-48.
178. Wink, M. (2008a). Plant secondary metabolism: diversity, function and its evolution. Nat. Prod. Commun. 3, 1205-1216.
179. Wink, M. (2008b). Evolutionary advantage and molecular modes of action of multi-component mixtures used in phytomedicine. Curr. DrugMetab. 9, 996-1009.
180. Wink, M. (2010a). Functions and Biotechnology of Plant Secondary Metabolites-Annual Plant Reviews, Vol. 39. Chichester:Wiley-Blackwell.
181. Wink,M. (2010b). Biochemistry of Plant Secondary Metabolism-Annual Plant Reviews, Vol. 40. Chichester: Wiley-Blackwell.
182. Wink, M., and Schimmer, O. (2010). 'Molecular modes of action of defensive secondary metabolites,' in Functions and Biotechnology of Plant Secondary Metabolites,Vol. 39, ed. M. Wink (Chichester: Wiley-Blackwell), 21-161.
183. Xu, W L.,Shen, H. L., Ao,Z. F., Chen, B. A., Xia, W., Gao, F., and Zhang, Y. N. (2006). Combination of tetrandrine as a potential-reversing agent with daunorubicin, etoposide and cytarabine for the treatment of refractory and relapsed acute myelogenous leukemia. Leuk. Res. 30,407-413.
184. Yasuda, K., Lan, L. B., Sanglard, D., Furuya, K., Schuetz, J. D., and Schuetz, E. G. (2002). Interaction of cytochrome P450 3A inhibitors with P-glycoprotein. J. Pharmacol. Exp. Ther. 303, 323-332.
185. Ye, J., Zheng, Y., and Liu, D. (2009). Reversal effect and its mechanism of ampelopsin on multidrug resistance in K562/ADR cells. Zhongguo Zhong YaoZaZhi 34,761-765.
186. Yoo, H. H., Lee, M., Chung, H. J., Lee, S. K., and Kim, D.-H. (2007). Effects of diosmin, a flavonoid glycoside in citrus fruits, on P-glycoprotein-mediated drug efflux in human intestinal Caco-2 cells. J. Agric. Food Chem. 55, 7620-7625.
187. Yoshida, N., Takagi, A., Kitazawa, H., Kawakami, J., and Adachi, I. (2005). Inhibition of P-glycoprotein-mediated transport by extracts of and monoterpenoids contained in Zanthoxyli fructus. Toxicol. Appl. Pharmacol. 209, 167-173.
188. You, G., and Morris, M. E. (2007). Drug Transporters-Molecular Characterization and Role in Drug Disposition. Hoboken, NJ: Wiley-Interscience.
189. You, M., Ma, X., Mukherjee, R., Farnsworth, N. R., Cordell, G. A., Kinghorn, A. D., and Pezzuto, J. M. (1994). Indole alkaloids from Peschiera laeta that enhance vinblastine-mediated cytotoxicity with multidrug-resistant cells. J. Nat. Prod. 57, 1517-1522.
190. You, M., Wickramaratne, D. B., Silva, G. L., Chai, H., Chagwedera, T. E., Farnsworth, N. R., Cordell, G. A., Kinghorn, A. D., and Pezzuto, J. M. (1995). (-)-Roemerine, an aporphine alkaloid from Annona sene-galensis that reverses the multidrug-resistance phenotype with cultured cells. J. Nat. Prod. 58, 598-604.
191. Zamora, J. M., Pearce, H. L., and Beck, W T. (1988). Physical-chemical properties shared by compounds that modulate multidrug resistance in human leukemic cells. Mol. Pharmacol. 33, 454-462.
192. Zhang, S., and Morris, M. E. (2003). Effects of the flavonoids biochanin A, morin, phloretin, and silymarin on P-glycoprotein-mediated transport. J. Pharmacol. Exp. Ther. 304, 1258-1267.
193. Zhang, S., Yang, X., and Morris, M. E. (2004). Flavonoids are inhibitors of breast cancer resistance protein (ABCG2)-mediated transport. Mol. Pharmacol. 65, 1208-1216.
194. Zhao, M., Bai, L., Wang, L., Toki, A., Hasegawa, T., Kikuchi, M., Abe, M., Sakai, J., Hasegawa, R., and Bai, Y (2007). Bioactive cardeno-lides from the stems and twigs of Nerium oleander. J. Nat. Prod. 70, 1098-1103.
195. Zhou, D. C., Zittoun, R., and Marie, J. P. (1995). Homoharringtonine, an effective new natural product in cancer chemotherapy. Bull. Cancer 82, 987-995.
196. Zhou, S., Lim, L. Y., and Chowbay, B. (2004). Herbal modulation of P-glycoprotein. Drug Metab. Rev. 36, 57-104.
197. Zhu, A., Wang, X., and Guo, Z. (2001). Study of tea polyphenol as a reversal agent for carcinoma cell lines' multidrug resistance (study of TP as a MDR reversal agent). Nucl. Med. Biol. 28, 735-740.
198. Zhu, X., Sui, M., and Fan, W (2005). In vitro and in vivo characterizations of tetrandrine on the reversal of P-glycoprotein-mediated drug resistance to paclitaxel. Anticancer Res. 25,1953-1962.
199. Zupko, I., Rethy, B., Hohmann, J., Molnar, J., Ocsovszki, I., and Falkay, G. (2009). Antitumor activity of alkaloids derived from Amaryllidaceae species. In vivo 23, 41-48.